Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cécile Reyes

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|August 12, 2022
Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle DysregulationLinda Silina, Florent Dufour, Audrey Rapinat, et al.
Cancer Cytopathology|October 28, 2015
Massively parallel DNA sequencing from routinely processed cytological smearsLaure Piqueret-Stephan, Charles Marcaillou, Cécile Reyes, et al.
The Journal of Clinical Endocrinology and Metabolism|May 17, 2021
G Protein-coupled Receptors in Radioiodine-refractory Thyroid Cancer in the Era of Precision MedicineValentine Suteau, Valérie Seegers, Mathilde Munier, et al.
Breast Cancer Research and Treatment|January 7, 2022
Feasibility of personalized screening and prevention recommendations in the general population through breast cancer risk assessment: results from a dedicated risk clinicMahasti Saghatchian, Marc Abehsera, Amina Yamgnane, et al.
The American Journal of the Medical Sciences|July 26, 2018
BRCA2 Loss-of-Function and High Sensitivity to Cisplatin-Based Chemotherapy in a Patient With a Pleomorphic Soft Tissue Sarcoma: Effect of Genomic MedicineCamille Tlemsani, Eric Pasmant, Pascaline Boudou-Rouquette, et al.
Journal of Hematology & Oncology|September 9, 2021
HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breastIvan Bièche, Florence Coussy, Rania El-Botty, et al.
The Journal of Pathology|October 6, 2021
Multilayer spectrum of intratumoral heterogeneity in basal bladder cancerNanor Sirab, Damien Drubay, Pascale Maillé, et al.
Cancers|January 21, 2022
PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast CancerSamyuktha Suresh, Solène Huard, Amélie Brisson, et al.
Neuroendocrinology|February 5, 2020
Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid MorphologyJerôme Cros, Nathalie Théou-Anton, Valérie Gounant, et al.
Cancer Research|December 8, 2010
High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patientsCécile Laurent, Fabien Valet, Nathalie Planque, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|August 12, 2022
Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle DysregulationLinda Silina, Florent Dufour, Audrey Rapinat, et al.
Cancer Cytopathology|October 28, 2015
Massively parallel DNA sequencing from routinely processed cytological smearsLaure Piqueret-Stephan, Charles Marcaillou, Cécile Reyes, et al.
The Journal of Clinical Endocrinology and Metabolism|May 17, 2021
G Protein-coupled Receptors in Radioiodine-refractory Thyroid Cancer in the Era of Precision MedicineValentine Suteau, Valérie Seegers, Mathilde Munier, et al.
Breast Cancer Research and Treatment|January 7, 2022
Feasibility of personalized screening and prevention recommendations in the general population through breast cancer risk assessment: results from a dedicated risk clinicMahasti Saghatchian, Marc Abehsera, Amina Yamgnane, et al.
The American Journal of the Medical Sciences|July 26, 2018
BRCA2 Loss-of-Function and High Sensitivity to Cisplatin-Based Chemotherapy in a Patient With a Pleomorphic Soft Tissue Sarcoma: Effect of Genomic MedicineCamille Tlemsani, Eric Pasmant, Pascaline Boudou-Rouquette, et al.
Journal of Hematology & Oncology|September 9, 2021
HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breastIvan Bièche, Florence Coussy, Rania El-Botty, et al.
The Journal of Pathology|October 6, 2021
Multilayer spectrum of intratumoral heterogeneity in basal bladder cancerNanor Sirab, Damien Drubay, Pascale Maillé, et al.
Cancers|January 21, 2022
PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast CancerSamyuktha Suresh, Solène Huard, Amélie Brisson, et al.
Neuroendocrinology|February 5, 2020
Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid MorphologyJerôme Cros, Nathalie Théou-Anton, Valérie Gounant, et al.
Cancer Research|December 8, 2010
High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patientsCécile Laurent, Fabien Valet, Nathalie Planque, et al.
Pageof 2